Lucira Health, Inc., a pioneering name in the diagnostics industry, is headquartered in the United States. Founded in 2014, the company has made significant strides in the development of innovative, rapid testing solutions for infectious diseases. Lucira Health is renowned for its unique molecular testing technology, which allows for accurate and timely results in the comfort of home. The company’s flagship product, the Lucira COVID-19 All-In-One Test Kit, exemplifies its commitment to accessible healthcare, providing users with results in under 30 minutes. With a focus on empowering individuals through reliable diagnostics, Lucira Health has positioned itself as a leader in the at-home testing market. Its achievements reflect a dedication to improving public health outcomes and enhancing patient convenience in the ever-evolving landscape of healthcare.
How does Lucira Health, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Lucira Health, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Lucira Health, Inc., headquartered in the US, currently does not have any publicly available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. As there are no emissions data or reduction initiatives reported, it is unclear how Lucira Health, Inc. is addressing its carbon footprint or contributing to climate action within the healthcare sector. The lack of information on emissions and climate commitments suggests that the company may still be in the early stages of developing a comprehensive sustainability strategy.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Lucira Health, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
